盐酸达泊西汀联合他达拉非治疗原发性早泄的临床研究

目的:探讨盐酸达泊西汀联合他达拉非治疗原发性早泄的疗效。方法:将100例患者随机分成治疗组和对照组,每组50例。治疗组口服他达拉非片5 mg,每天1次,性交前按需口服盐酸达泊西汀片30 mg。对照组只按需口服盐酸达泊西汀片30 mg。疗程2个月。治疗期间嘱患者进行规律的性生活,每周1-2次,并做好相关记录。治疗前后行阴道内射精潜伏期(intravaginal ejaculation latency,IELT)IELT测评、患者及配偶性生活满意度评分。结果:与治疗前相比,两组治疗后IELT、患者及配偶满意度均有明显改善,差异具有统计学意义(P0.05)。而且治疗后治疗组与对照组比较,治疗组的IELT、患者及配偶满意度改善更为明显,差异亦具有统计学意义(P0.05)。常见不良反应有颜面潮红、头晕、鼻塞,无需特殊处理,症状均自行缓解。结论:盐酸达泊西汀联合他达拉非治疗原发性早泄安全有效。

Clinical Efficacy of Dapoxetine Hydrochloride Combined with Tadalafil in the Treatment of Primary Premature Ejaculation

ABSTRACT Objective: To explore the effect of dapoxetine hydrochloride combined with tadalafil for the treatment of primary pre- mature ejaculation. Methods: One hundred patients were randomly divided into treatment group and control group, 50 cases in each group. The treatment group was given oral tadalafil 5 mg, once a day, and on-demand oral 30 mg dapoxetine hydrochloride before sexual intercourse. The control group was treated with only on-demand oral 30 mg dapoxetine hydrochloride, lasting for 2 months. The patients during treatment were instructed for regular sex, 1-2 times a week, and the relevant records were kept. The IELT, the sexual satisfaction score of the patients and their spouse before and after the treatment was evaluated. Results: Compared with before treatment, the intrav- aginal ejaculation latency (IELT) IELT, and the sexual satisfaction of the patients and their spouses was improved significantly after treat- ment in two groups (P<0.05). When the treatment group compared with control group, the improvements of IELT, patient and spouse sat- isfaction of treatment group were more apparent after treatment. And the differences were statistically significant (P<0.05). The common adverse reactions included facial blushing, dizziness, nasal congestion, and these symptoms could be relieved by no special treatment. Conclusion: The treatment of dapoxetine hydrochloride combined with tadalafil is safe and effective for primary premature ejaculation.